Article by David Brown, Lift News
The Hydropothecary Corporation today announced a voluntary stop-sale and stop-shipment on all products due to detection of myclobutanil, a fungicide not approved for use on cannabis in Canada. The company emphasizes this is not a recall of product, as the fungicide was found on plants, not finished cannabis products.
The company says the source of the myclobutanil is unknown and that they have been doing their own third party testing since February that were negative for pesticides at a level of 0.05 ppm. This is the first result from new random testing being conducted by Health Canada in response to recent recalls of cannabis products related to the use of unauthorized pesticides. The regulator has been collecting dozens of random samples from different producers since February of this year.
The Hydropothecary posted an announcement on their website today noting they had contacted all registered patients to inform them of the announcement.
Health Canada categorizes all recalls of any products under their review in one of three types, from “seriously adverse health consequences,” to products that “may cause temporary adverse health consequences, or where the probability of serious adverse health consequences is remote,” to products that are “not likely to cause adverse health consequences.” Earlier this year, Health Canada began listing recalls of cannabis of all kinds, regardless of any risk to public health.
OrganiGram and Mettrum had to issue recalls of several batches of product over detected myclobutanil “and/or” bifenazate in the recent past. Aurora also issued a recall based on products they had purchased from OrganiGram and resold to their patients.